A review of the value of point-of-care testing for community-acquired pneumonia.

Andrea PalomequeCatian CillonizAlba Soler-ComasJoan Canseco-RibasNona Rovira-RibaltaAnna MotosAntoni Torres

Published in: Expert review of molecular diagnostics (2024)

POCT involves rapid diagnostic assays that can be performed at the bedside especially in cases of severe CAP and immunocompromised patients. These tests can produce results that could help guide initial therapy and management.

Keyphrases

community acquired pneumonia
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
early onset
stem cells
patient reported outcomes
mesenchymal stem cells
bone marrow
cell therapy
respiratory failure